XML 89 R32.htm IDEA: XBRL DOCUMENT v3.20.1
Related Party Transaction (Tables)
 12 Months Ended
Dec. 31, 2019
Related Party Transaction  
Schedule of common stock sold to related parties

 

 

 

 

 

 

 

 

    

March 2018 Public Offering

 

    

Number of

 

Aggregate

 

 

 

Shares of

 

Purchase

 

    

Common Stock

    

Price

Owners of More Than 5% of Our Common Stock

 

 

 

 

 

 

FMR LLC

 

 

1,176,470

 

$

9,999,995

OrbiMed Advisors LLC (1)

 

 

588,235

 

 

4,999,998

Novo Holdings A/S (2)

 

 

1,176,470

 

 

9,999,995

Adams Street Partners (3)

 

 

588,235

 

 

4,999,998

Board of Directors

 

 

 

 

 

 

Richard A. Miller, M.D.

 

 

100,000

 

 

850,000

 

(1)

Peter Thompson, M.D., a member of our Board of Directors since November 2014, is a Private Equity Partner at OrbiMed Advisors, LLC.

(2)

Peter Moldt, Ph.D., a Partner at Novo Ventures (US) Inc., which provide certain consultancy services to Novo Holdings A/S, served as a member of our Board of Directors from January 2015 to January 2019.

(3)

Elisha P. (Terry) Gould III, a member of our Board of Directors since November 2014, is a Partner at Adams Street Partners, LLC.